Literature DB >> 20970162

Severe hepatosplenic schistosomiasis: clinicopathologic study of 102 cases undergoing splenectomy.

Yuesheng Li1, Dongliang Chen, Allen G Ross, Melissa L Burke, Xinling Yu, Robert S Li, Jie Zhou, Donald P McManus.   

Abstract

We present the preoperative findings of 102 patients who underwent successful splenectomy for advanced schistosomiasis japonica. All patients were symptomatic for schistosomiasis and had splenomegaly greater than or equal to II according to the Hackett criteria. Before surgery, all patients underwent clinical examination including full blood count; fibrinogen and serum protein levels; liver function tests; and serology for hepatitis B, C, and D. Ultrasound examination of the liver and spleen and liver histology for evidence of pathology were also undertaken. Ninety patients had a treatment history for schistosomiasis. Fifty-six patients were seropositive for hepatitis B virus antibody, and 6 patients were seropositive for hepatitis C virus antibody. Immunohistochemical testing of the liver samples confirmed that 45 patients were positive for hepatitis B virus surface antigen, thereby indicating active infection. A total of 66.7% of patients had fibrosis stages II to III by ultrasound; and 76.5% of patients had portal vein inner diameter greater than 12 mm, indicating portal vein hypertension. A total of 83.2% of patients showed various stages of esophageal varicosis via x-ray, and 81.4% had fibrotic stages III to IV by liver biopsy. Coinfection with hepatitis B virus accelerated the development of liver fibrosis. There was moderate concordance between the fibrosis assessed by ultrasonography and histopathology, indicating that ultrasound underestimates the true pathology. Combined assessment is needed to improve the diagnosis of clinical hepatic fibrosis. Crown
Copyright © 2011. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20970162     DOI: 10.1016/j.humpath.2010.05.020

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

Review 1.  Schistosomiasis research in the dongting lake region and its impact on local and national treatment and control in China.

Authors:  Donald P McManus; Darren J Gray; Allen G Ross; Gail M Williams; Hong-Bin He; Yue-Sheng Li
Journal:  PLoS Negl Trop Dis       Date:  2011-08-30

2.  Antischistosomal Activity of Two Active Constituents Isolated from the Leaves of Egyptian Medicinal Plants.

Authors:  Sanaa A Ali; Nagy S El-Regal; Samar M Saeed
Journal:  Infect Dis (Auckl)       Date:  2015-06-15

Review 3.  Schistosomiasis, hepatitis B and hepatitis C co-infection.

Authors:  Gasim I Gasim; Abdelhaleem Bella; Ishag Adam
Journal:  Virol J       Date:  2015-02-08       Impact factor: 4.099

4.  Prevention and control of schistosomiasis: a current perspective.

Authors:  Marianette T Inobaya; Remigio M Olveda; Thao Np Chau; David U Olveda; Allen Gp Ross
Journal:  Res Rep Trop Med       Date:  2014-10-17

5.  Derivation and external validation of a model to predict 2-year mortality risk of patients with advanced schistosomiasis after discharge.

Authors:  Guo Li; Shanshan Huang; Lifei Lian; Xiaoyan Song; Wenzhe Sun; Jinfeng Miao; Bohan Li; Yong Yuan; Shengfan Wu; Xiaoyan Liu; Zhou Zhu
Journal:  EBioMedicine       Date:  2019-08-23       Impact factor: 8.143

6.  Potential Gut Microbiota Features for Non-Invasive Detection of Schistosomiasis.

Authors:  Datao Lin; Qiuyue Song; Jiahua Liu; Fang Chen; Yishu Zhang; Zhongdao Wu; Xi Sun; Xiaoying Wu
Journal:  Front Immunol       Date:  2022-07-14       Impact factor: 8.786

7.  Health access livelihood framework reveals potential barriers in the control of schistosomiasis in the Dongting Lake area of Hunan Province, China.

Authors:  Julie Balen; Zhao-Chun Liu; Donald P McManus; Giovanna Raso; Jürg Utzinger; Shui-Yuan Xiao; Dong-Bao Yu; Zheng-Yuan Zhao; Yue-Sheng Li
Journal:  PLoS Negl Trop Dis       Date:  2013-08-01

8.  Hemostatic dysfunction is increased in patients with hepatosplenic schistosomiasis mansoni and advanced periportal fibrosis.

Authors:  Luiz Arthur Calheiros Leite; Adenor Almeida Pimenta Filho; Caíque Silveira Martins da Fonseca; Bianka Santana dos Santos; Rita de Cássia dos Santos Ferreira; Silvia Maria Lucena Montenegro; Edmundo Pessoa Lopes; Ana Lúcia Coutinho Domingues; James Stuart Owen; Vera Lúcia de Menezes Lima
Journal:  PLoS Negl Trop Dis       Date:  2013-07-18

9.  Nomograms to predict 2-year overall survival and advanced schistosomiasis-specific survival after discharge: a competing risk analysis.

Authors:  Guo Li; Lifei Lian; Shanshan Huang; Jinfeng Miao; Huan Cao; Chengchao Zuo; Xiaoyan Liu; Zhou Zhu
Journal:  J Transl Med       Date:  2020-05-06       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.